Applied nutritional investigationA randomized controlled clinical trial investigating the effect of DASH diet on insulin resistance, inflammation, and oxidative stress in gestational diabetes
Introduction
Gestational diabetes mellitus (GDM) is a condition in which pregnant women without previously diagnosed diabetes exhibit high blood glucose levels especially during the third trimester [1]. It affects 3% to 6% of all pregnancies, depending on the studied population [2]. The precise mechanisms underlying GDM remain unknown. The main hallmark of GDM is increased insulin resistance [3]. Increased production of placental hormones, especially cortisol, progesterone, human chorionic somatomammotropin (HCS), and to a lesser extent increased fat deposits during pregnancy result in insulin resistance during pregnancy [3], [4]. Elevated circulating levels of inflammatory markers, particularly highly sensitive C-reactive protein (hs-CRP) and tumor necrosis factor (TNF)-α, in GDM can predict the progression to type 2 diabetes (T2D) later in life [5], [6], [7]. Some studies also have shown that enhanced lipid peroxidation and oxidative stress results in the development of GDM [8], [9]. Gestational diabetes has been associated with increased risk for developing fetal macrosomia, prematurity, birth trauma, fetal death, and respiratory distress syndrome in offsprings, as well as maternal morbidity [10], [11], [12], [13], [14]. Pregnant women with GDM are at an increased risk for developing T2D later in life [15].
Various strategies, including diet therapy [16], [17], the use of oral hypoglycemic agents [18], and insulin injections [19], have been suggested for management of GDM. The use of antioxidants, vitamins E and A, have resulted in a lower circulating level of inflammatory factors and biomarkers of oxidative stress during pregnancy [20], [21], [22]. The Dietary Approaches to Stop Hypertension (DASH) eating plan was originally suggested for patients with hypertension [23]; however, its effects on cardiovascular risk factors [24], features of metabolic syndrome [25], and metabolic profile of diabetic patients [26] have recently been shown. Azadbakht et al. [26] have demonstrated that consumption of the DASH diet for 8 wk was associated with decreased serum levels of hs-CRP in patients with diabetes. These investigators also reported the beneficial effects of this dietary pattern on CRP, coagulation abnormalities, and hepatic function tests [26]. Improvements in insulin sensitivity and lipid profiles also have been documented with adherence to the DASH diet along with exercise and weight loss in hypertensive overweight patients [27].
The DASH diet is a low-glycemic index, low energy-dense diet that contains higher amounts of dietary fiber, phytoestrogens, potassium, magnesium, folic acid, and other beneficial nutrients [24], [25]. To the best of our knowledge, no reports are available indicating the effects of the DASH diet on insulin resistance, inflammation, and biomarkers of oxidative stress in pregnant women with GDM. The aim of the current study, therefore, was to investigate the effects of the DASH eating plan on insulin resistance, serum hs-CRP, and biomarkers of oxidative stress on pregnant women with GDM.
Section snippets
Participants
This randomized, two-arm, parallel clinical trial was carried out in Kashan, Iran, from April 2011 to December 2011. On the basis of the sample size formula suggested for randomized clinical trials [26] and considering the type I error of 5% (α = 0.05), type II error of 20% (β = 0.2; Power = 80%), and serum hs-CRP level as a key variable, we reached the sample size of 16 women for each group. Pregnant women ages 18 to 40 y diagnosed with GDM by a 100-g oral glucose tolerance test at 24 to 28 wk
Results
Mean age, pre-pregnancy weight, and BMI were not statistically different between the two groups (Table 1). Baseline weight and BMI as well as postintervention means for these variables were not significantly different between the DASH and control groups.
Based on 3-d dietary records, no statistically significant difference was seen between the two groups in terms of energy and protein intake; however, significant differences were observed in dietary intakes of carbohydrates, fats, saturated
Discussion
We found that consumption of the DASH eating pattern in pregnant women with GDM had beneficial effects on FPG, serum insulin levels, HOMA-IR score, and biomarkers of oxidative stress. Total energy intake of participants in the control and the DASH groups was the same; however, the energy density of the DASH diet was lower than the control diet. To our knowledge, this study is the first reporting the effects of the DASH diet on insulin resistance and biomarkers of oxidative stress in GDM.
Conclusion
Consumption of the DASH diet in pregnant women with GDM had beneficial effects on FPG, serum insulin levels, HOMA-IR score, plasma TAC, and total GSH levels. The effects of this dietary pattern on pregnancy outcomes need to be investigated in future studies.
Acknowledgment
The present study was supported by a grant (No. 91104) from the vice-chancellor for research, KUMS, and Iran. The authors would like to thank the staff of Naghavi and Shaheed Beheshti Clinics (Kashan, Iran) for their assistance in this project. The study was supported by a grant (no. 91104) from Kashan University of Medical Sciences.
Clinical trial registration number: IRCT201204065623N2.
Name of trial registry: Effects of the Dietary Approaches to Stop Hypertension (DASH) on metabolic profiles
References (54)
- et al.
Gestational diabetes and subclinical inflammation: Evaluation of first year postpartum outcomes
Diabetes Res Clin Pract
(2011) - et al.
Management of diabetes mellitus complicating pregnancy
Obstet Gynecol
(2003) - et al.
Natural course of gestational diabetes mellitus: Long term follow up of women in the SPAWN study
BJOG
(2002) - et al.
Nutrient intake of women with and without gestational diabetes with a specific focus on fatty acids
Nutrition
(2006) - et al.
Oxidant and antioxidant status in mothers and their newborns according to birthweight
Eur J Obstet Gynecol Reprod Biol
(2008) - et al.
Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea
Exp Eye Res
(2005) - et al.
The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients
J Nutr
(2011) - et al.
Dating gestational age by last menstrual period, symphysis-fundal height, and ultrasound in urban Pakistan
Int J Gynaecol Obstet
(2010) - et al.
Higher carbohydrate intake is associated with decreased incidence of newborn macrosomia in women with gestational diabetes
J Am Diet Assoc
(2001) - et al.
Gestational diabetes and insulin resistance: Role in short- and long-term implications for mother and fetus
J Nutr
(2003)
A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation
Clin Biochem
Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women
Am J Clin Nutr
A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: Results from a randomized controlled feeding study
Atherosclerosis
Effects of low- and high-glycemic index/glycemic load diets on coronary heart disease risk factors in overweight/obese men
Metabolism
Dietary antioxidants: Do they have a role to play in the ongoing fight against abnormal glucose metabolism?
Nutrition
Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults
Nutrition
Association of six single nucleotide polymorphisms with gestational diabetes mellitus in a Chinese population
PLoS One
Gestational diabetes mellitus: Non-insulin management
Indian J Endocrinol Metab
Intermediate metabolism in normal pregnancy and in gestational diabetes
Diabetes Metab Res Rev
Insulin therapy in pregnancy complicated by diabetes: Are insulin analogs a new tool?
Diabetes Metab Res Rev
Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices
Ginekol Pol
Gestational diabetes: Implications for cardiovascular health
Curr Diab Rep
The role of oxidative stress in the pathophysiology of gestational diabetes mellitus
Antioxid Redox Signal
Antioxidant vitamins and lipoperoxidation in non-pregnant, pregnant, and gestational diabetic women: Erythrocytes osmotic fragility profiles
J Clin Med Res
Prevalence of gestational diabetes and associated maternal and neonatal complications in a fast-developing community: Global comparisons
Int J Womens Health
Management of diabetes mellitus complicating pregnancy
Obstet Gynecol
Maternal diabetes in pregnancy: Early and long-term outcomes on the offspring and the concept of “metabolic memory.”
Exp Diabetes Res
Cited by (128)
Associations of adherence to the DASH diet and Mediterranean diet with maternal c-reactive protein levels during pregnancy
2024, Nutrition, Metabolism and Cardiovascular DiseasesThe influence of the dietary exposome on oxidative stress in pregnancy complications
2022, Molecular Aspects of MedicineCitation Excerpt :Nutritional interventions in patients with different forms of pregnancy complication and different outcome measures have been examined. One of these investigations is the Dietary Approaches to Stop Hypertension (DASH) (Asemi et al., 2013, 2014). This diet was originally designed to normalize blood pressure in patients with hypertension.
ZA and AE contributed in conception, design, statistical analysis, and drafting of the manuscript. ZT, MS, and SS contributed in data collection and manuscript drafting. AE supervised the study. AE is the guarantor who takes full responsibility for the work as a whole, including the study design, access to data, and the decision to submit and publish the manuscript. None of the authors had any personal or financial conflict of interest. All authors approved the final version for submission Clinical trial registration number: IRCT201204065623N2.